Cargando…
Ambivalent anticipation: How people with Alzheimer’s disease value diagnosis in current and envisioned future practices
Emergent biomarkers for Alzheimer's disease (AD) are expected to provide earlier and more precise diagnoses. However, even if biomarkers live up to these expectations, it cannot be taken for granted that patients actually would value an earlier and more precise AD diagnosis. Based on an intervi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248062/ https://www.ncbi.nlm.nih.gov/pubmed/33635548 http://dx.doi.org/10.1111/1467-9566.13238 |